Loading clinical trials...
Loading clinical trials...
A double blind, randomized, cross over study in type 1 diabetic patients. 20 patients, age 18-65 years is treated with spironolacton (Hexalacton (R)) for 60 days followed by 60 days treatment with pla...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Steno Diabetes Center Copenhagen
NCT05297708 · Elevated Blood Pressure
NCT07590193 · Diabetes Mellitus, Type 2
NCT05765786 · Primary Aldosteronism, High Blood Pressure
NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions